Suppr超能文献

慢性丙型肝炎病毒感染与炎症:对肝脏及肝外表现的临床影响

Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

作者信息

Zampino Rosa, Marrone Aldo, Restivo Luciano, Guerrera Barbara, Sellitto Ausilia, Rinaldi Luca, Romano Ciro, Adinolfi Luigi E

机构信息

Rosa Zampino, Aldo Marrone, Division of Internal Medicine and Hepatology, Second University of Naples Polyclinic Hospital, 80100 Naples, Italy.

出版信息

World J Hepatol. 2013 Oct 27;5(10):528-40. doi: 10.4254/wjh.v5.i10.528.

Abstract

The liver has a central role in regulating inflammation by its capacity to secrete a number of proteins that control both local and systemic inflammatory responses. Chronic inflammation or an exaggerated inflammatory response can produce detrimental effects on target organs. Chronic hepatitis C virus (HCV) infection causes liver inflammation by complex and not yet well-understood molecular pathways, including direct viral effects and indirect mechanisms involving cytokine pathways, oxidative stress and steatosis induction. An increasing body of evidence recognizes the inflammatory response in chronic hepatitis C as pathogenically linked to the development of both liver-limited injury (fibrosis, cirrhosis and hepatocellular carcinoma) and extrahepatic HCV-related diseases (lymphoproliferative disease, atherosclerosis, cardiovascular and brain disease). Defining the complex mechanisms of HCV-induced inflammation could be crucial to determine the global impact of infection, to estimate progression of the disease, and to explore novel therapeutic approaches to avert HCV-related diseases. This review focuses on HCV-related clinical conditions as a result of chronic liver and systemic inflammatory states.

摘要

肝脏通过分泌多种控制局部和全身炎症反应的蛋白质,在调节炎症方面发挥着核心作用。慢性炎症或过度的炎症反应会对靶器官产生有害影响。慢性丙型肝炎病毒(HCV)感染通过复杂且尚未完全了解的分子途径导致肝脏炎症,这些途径包括直接的病毒效应以及涉及细胞因子途径、氧化应激和脂肪变性诱导的间接机制。越来越多的证据表明,慢性丙型肝炎中的炎症反应在发病机制上与肝脏局限性损伤(纤维化、肝硬化和肝细胞癌)以及肝外HCV相关疾病(淋巴增殖性疾病、动脉粥样硬化、心血管疾病和脑部疾病)的发展有关。明确HCV诱导炎症的复杂机制对于确定感染的整体影响、评估疾病进展以及探索预防HCV相关疾病的新治疗方法可能至关重要。本综述重点关注慢性肝脏和全身炎症状态导致的HCV相关临床情况。

相似文献

1
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.
World J Hepatol. 2013 Oct 27;5(10):528-40. doi: 10.4254/wjh.v5.i10.528.
2
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms.
World J Gastroenterol. 2014 Apr 7;20(13):3410-7. doi: 10.3748/wjg.v20.i13.3410.
3
Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy.
World J Gastroenterol. 2018 Dec 21;24(47):5297-5311. doi: 10.3748/wjg.v24.i47.5297.
4
Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management.
Minerva Med. 2021 Apr;112(2):188-200. doi: 10.23736/S0026-4806.20.07129-3. Epub 2020 Nov 18.
6
Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients.
Curr Opin HIV AIDS. 2015 Sep;10(5):309-15. doi: 10.1097/COH.0000000000000175.
8
The predictive value of steatosis in hepatitis C virus infection.
Expert Rev Gastroenterol Hepatol. 2013 Mar;7(3):205-13. doi: 10.1586/egh.13.7.
9
Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus.
Am J Physiol Gastrointest Liver Physiol. 2006 May;290(5):G847-51. doi: 10.1152/ajpgi.00522.2005.

引用本文的文献

1
Genetic and transcriptional insights reveal hepatitis C virus as a driver of kidney cancer.
Infect Agent Cancer. 2025 Sep 2;20(1):63. doi: 10.1186/s13027-025-00693-9.
4
Effects of oxidative stress on viral infections: an overview.
Npj Viruses. 2025 Apr 12;3(1):27. doi: 10.1038/s44298-025-00110-3.
5
Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target.
Liver Res. 2022 Sep 19;6(4):203-213. doi: 10.1016/j.livres.2022.09.003. eCollection 2022 Dec.
6
Do oxidized low-density lipoproteins link to extra hepatic manifestations in chronic, non-cirrhotic HCV patients?
Metabol Open. 2024 Dec 10;25:100339. doi: 10.1016/j.metop.2024.100339. eCollection 2025 Mar.

本文引用的文献

2
Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C.
Clin Gastroenterol Hepatol. 2014 Feb;12(2):334-40. doi: 10.1016/j.cgh.2013.05.008. Epub 2013 May 22.
6
Cannabinoid signaling and liver therapeutics.
J Hepatol. 2013 Oct;59(4):891-6. doi: 10.1016/j.jhep.2013.03.032. Epub 2013 Apr 6.
8
Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.
J Hepatol. 2013 Feb;58(2):234-9. doi: 10.1016/j.jhep.2012.10.015. Epub 2012 Oct 22.
9
HCV-related nervous system disorders.
Clin Dev Immunol. 2012;2012:236148. doi: 10.1155/2012/236148. Epub 2012 Jul 30.
10
Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C.
J Viral Hepat. 2012 Sep;19(9):608-14. doi: 10.1111/j.1365-2893.2011.01580.x. Epub 2012 Jan 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验